12-Week Study on RO7017773 for Autism Spectrum Disorder in 15-45 Year Olds

Study Description

This study aims to examine how RO7017773 can treat Autism Spectrum Disorder in those aged 15-45 with a score of >/=50 on the Wechsler Abbreviated Scale of Intelligence (WASI-II). It will measure efficacy, safety, tolerability, and pharmacokinetics of the drug.

Study Details

Registry ID:

NCT04299464

Conditions:

Autism Spectrum Disorder (ASD)

Phase:

Phase 2

Target Enrollment:

104 participants

Start Date:

March 31, 2021

Age Range:

15–45 years

Healthy Volunteers:

No

Study Locations (44 sites)

• Istituto Scientifico Medea
  Bosisio Parini (LC), LombardiaItaly, Italy
• IRCCS Fondazione Stella Maris; U.O. Complessa NPI 3 - Psichiatria dello sviluppo
  Calambrone (PI), ToscanaItaly, Italy
• Istituto Scientifico Medea; U.O Psicopatologia età evolutiva
  Bosisio Parini (LC), LombardiaItaly, Italy
• P.O. Gaspare Rodolico
  Catania, SiciliaItaly, Italy
• P.O. Gaspare Rodolico; UOC Clinica Psichiatrica
  Catania, SiciliaItaly, Italy
• Hospital General Universitario Gregorio Marañon
  MadridSpain, Spain
• Hospital Universitario Infanta Leonor; Servicio de Psiquiatría
  MadridSpain, Spain
• Hospital General Universitario Gregorio Marañon; Instituto Provincial de Psiquiatría
  MadridSpain, Spain
• IGAIN (Instituto Global de Atención Integral al Neurodesarrollo)
  Barcelona, BarcelonaSpain, Spain
• Hospital Universitari Vall d'Hebron; Sevicio de Psiquiatría
  BarcelonaSpain, Spain
• Hospital Universitari Vall d'Hebron; Sevicio de Psiquiatría
  Barcelona, BarcelonaSpain, Spain
• Hospital Universitari Vall d'Hebron
  BarcelonaSpain, Spain
• IGAIN (Instituto Global de Atención Integral al Neurodesarrollo)
  BarcelonaSpain, Spain
• Azienda Ospedaliera Universitaria Federico II; U.O.S.D. Neuropsichiatria Infantile
  Napoli, CampaniaItaly, Italy
• Azienda Ospedaliera Universitaria Federico II; U.O.S.D. Neuropsichiatria Infantile
  NapoliItaly, Italy
• AOU Policlinico Tor Vergata, Università Roma Tor Vergata
  Roma, LazioItaly, Italy
• AOU Policlinico Tor Vergata, Università Roma Tor Vergata
  Roma, LazioItaly, Italy
• IRCCS Fondazione Stella Maris; U.O. Complessa NPI 3 - Psichiatria dello sviluppo
  Calambrone, Pisa (pi)Italy, Italy
• Ist. G. Gaslini
  Genova, LiguriaItaly, Italy
• Ist. G. Gaslini; UOC Neuropsichiatria Infantile
  Genova, LiguriaItaly, Italy
• Ist. G. Gaslini; UOC Neuropsichiatria Infantile
  Genova, LiguriaItaly, Italy
• ASST di Pavia; Dip. di Scienze del Sistema Nervoso e del Comportamento
  Pavia, LombardiaItaly, Italy
• ASST di Pavia; Dip. di Scienze del Sistema Nervoso e del Comportamento
  Pavia, Pavia (pv)Italy, Italy
• Istituto Scientifico Medea; U.O Psicopatologia età evolutiva
  Bosisio Parini, Lecco (lc)Italy, Italy
• Janeway Childrens Health
  St. John's, Newfoundland and LabradorCanada, Canada
• Janeway Childrens Health; and Rehabilitation Centre
  St. John's, Newfoundland and LabradorCanada, Canada
• Yale University / Yale-New Haven Hospital
  New Haven, ConnecticutUnited States, United States
• Montefiore Medical Center
  Bronx, New YorkUnited States, United States
• Nathan Kline Institute
  Orangeburg, New YorkUnited States, United States
• APG- Advanced Psychiatric Group
  Orlando, FloridaUnited States, United States
• UPMC Western Psychiatric Institute and Clinic
  Pittsburgh, PennsylvaniaUnited States, United States
• Holland Bloorview Kids Rehabilitation Hospital; Autism Research Centre
  East York,  ontarioCanada, Canada
• Holland Bloorview Kids Rehabilitation Hospital
  East York, OntarioCanada, Canada
• Holland Bloorview Kids Rehabilitation Hospital; Autism Research Centre
  East York, OntarioCanada, Canada
• University Hospitals
  Cleveland, OhioUnited States, United States
• London Health Sciences Centre
  London, OntarioCanada, Canada
• London Health Sciences Centre; Victoria Hospital
  London, OntarioCanada, Canada
• Ohio State University
  Columbus, OhioUnited States, United States
• Vanderbilt Medical Center
  Nashville, TennesseeUnited States, United States
• Rush University Medical Center
  Chicago, IllinoisUnited States, United States
• University of Minnesota
  Minneapolis, MinnesotaUnited States, United States
• Southwest Autism Research and Resource Center
  Phoenix, ArizonaUnited States, United States
• University of Alberta
  EdmontonCanada, Canada
• Okanagan Clinical Trials
  Kelowna, British ColumbiaCanada, Canada

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →